Time to initiation of antiretroviral therapy in HIV-infected patients diagnosed with an opportunistic disease: a cohort study

被引:6
|
作者
Deconinck, L. [1 ,2 ,5 ]
Yazdanpanah, Y. [2 ,3 ]
Gilson, R. J. [1 ,4 ]
Melliez, H. [5 ]
Viget, N. [5 ]
Joly, V. [3 ]
Sabin, C. A. [1 ]
机构
[1] UCL, UCL Res Dept Infect & Populat Hlth, London, England
[2] Paris Diderot Univ, Decis Sci Infect Dis Prevent Control & Care, IAME, Sorbonne Paris Cite,UMR 1137, Paris, France
[3] Bichat Claude Bernard Hosp, Dept Infect Dis, Paris, France
[4] Cent & North West London NHS Fdn Trust, Mortimer Market Ctr, London, England
[5] Tourcoing Hosp, Lille Sch Med, Dept Infect Dis, Tourcoing, France
关键词
AIDS-related opportunistic infections; antiretroviral therapy; HIV; time to treatment; CONSEQUENCES; AIDS;
D O I
10.1111/hiv.12201
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
ObjectivesThe aim of the study was to identify factors associated with the time between opportunistic disease (OD) diagnosis and antiretroviral therapy (ART) initiation in HIV-infected patients presenting for care with an OD, and to evaluate the outcomes associated with any delay. MethodsA multicentre cohort study was undertaken in London, Paris and Lille/Tourcoing. The medical records of patients diagnosed from 2002 to 2012 were reviewed. ResultsA total of 437 patients were enrolled in the study: 70% were male, the median age was 40 years, 42% were from sub-Saharan Africa, 68% were heterosexual, the median CD4 count was 40cells/L, and the most common ODs were Pneumocystis pneumonia (37%), tuberculosis (24%), toxoplasmosis (12%) and Kaposi's sarcoma (11%). Of these patients, 400 (92%) started ART within 24 weeks after HIV diagnosis, with a median time from OD diagnosis to ART initiation of 30 [interquartile range (IQR) 16-58] days. Patients diagnosed between 2009 and 2012 had a shorter time to ART initiation than those diagnosed in earlier years [hazard ratio (HR) 2.07; 95% confidence interval (CI) 1.58-2.72]. Factors associated with a longer time to ART initiation were a CD4 count200cells/L (HR 0.30; 95% CI 0.20-0.44), tuberculosis (HR 0.40; 95% CI 0.30-0.55) and diagnosis in London (HR 0.62; 95% CI 0.48-0.80). Patients initiating deferred' ART (by 30 days) exhibited no difference in disease progression or immunovirological response compared with patients who had shorter times to ART initiation. Patients in the deferred' group were less likely to have ART modifications (HR 0.69; 95% CI 0.48-1.00) and had shorter in-patient stays (mean 14.2 days shorter; 95% CI 8.9-19.5 days) than patients in the group whose ART was not deferred. ConclusionsThe time between OD diagnosis and ART initiation remains heterogeneous and relatively long, particularly in individuals with a high CD4 count or tuberculosis or those diagnosed in London. Deferring ART was associated with fewer ART modifications and shorter in-patient stays.
引用
收藏
页码:219 / 229
页数:11
相关论文
共 50 条
  • [31] Nephrotoxicity associated with antiretroviral therapy in HIV-infected patients
    Harris, Marianne
    EXPERT OPINION ON DRUG SAFETY, 2008, 7 (04) : 389 - 400
  • [32] ANTIRETROVIRAL THERAPY AND ARTERIAL ELASTICITY IN HIV-INFECTED PATIENTS
    Kundro, Mariana A.
    Viloria, Guillermo A.
    Toibaro, Javier J.
    Losso, Marcelo H.
    MEDICINA-BUENOS AIRES, 2017, 77 (05) : 365 - 369
  • [33] Interruption of antiretroviral therapy in chronically HIV-infected patients
    Amador, C
    Pasquau, F
    Ena, J
    Benito, C
    de Apodaca, RFR
    MEDICINA CLINICA, 2005, 125 (02): : 41 - 45
  • [34] Nephrotoxicity Associated with Antiretroviral Therapy in HIV-Infected Patients
    Rho, Mira
    Perazella, Mark A.
    CURRENT DRUG SAFETY, 2007, 2 (02) : 147 - 154
  • [35] Factors associated with virological response in HIV-infected patients failing antiretroviral therapy:: a prospective cohort study
    Fournier, S
    Chaffaut, C
    Maillard, A
    Loze, B
    Lascoux, C
    Gérard, L
    Timsit, J
    David, F
    Bergmann, JF
    Oksenhendler, E
    Sereni, D
    Chevret, S
    Molina, JM
    HIV MEDICINE, 2005, 6 (02) : 129 - 134
  • [36] PERICARDIAL EFFUSION OF HIV-INFECTED PATIENTS - RESULTS OF A PROSPECTIVE MULTICENTER COHORT STUDY IN THE ERA OF ANTIRETROVIRAL THERAPY
    Lind, A.
    Reinsch, N.
    Neuhaus, K.
    Esser, S.
    Brockmeyer, N.
    Potthoff, A.
    Pankuweit, S.
    Erbel, R.
    Maisch, B.
    Neumann, T.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2011, 16 (11) : 480 - 483
  • [37] Pericardial effusion of HIV-infected patients - results of a prospective multicenter cohort study in the era of antiretroviral therapy
    A. Lind
    N. Reinsch
    K. Neuhaus
    S. Esser
    N. Brockmeyer
    A. Potthoff
    S. Pankuweit
    R. Erbel
    B. Maisch
    T. Neumann
    European Journal of Medical Research, 16
  • [38] Timing and Predictors of Initiation on Antiretroviral Therapy Among Newly-Diagnosed HIV-Infected Persons in South Africa
    Larsen, Anna
    Cheyip, Mireille
    Tesfay, Abraham
    Vranken, Peter
    Fomundam, Henry
    Wutoh, Anthony
    Aynalem, Getahun
    AIDS AND BEHAVIOR, 2019, 23 (02) : 375 - 385
  • [39] Timing and Predictors of Initiation on Antiretroviral Therapy Among Newly-Diagnosed HIV-Infected Persons in South Africa
    Anna Larsen
    Mireille Cheyip
    Abraham Tesfay
    Peter Vranken
    Henry Fomundam
    Anthony Wutoh
    Getahun Aynalem
    AIDS and Behavior, 2019, 23 : 375 - 385
  • [40] Nitric oxide levels in HIV-infected, untreated patients and HIV-infected patients receiving antiretroviral therapy
    Soccal, Renata Mezomo
    Mainardi de Carvalho, Jose Antonio
    Bochi, Guilherme Vargas
    Moresco, Rafael Noal
    Paz da Silva, Jose Edson
    BIOMEDICINE & PHARMACOTHERAPY, 2016, 79 : 302 - 307